Shuto S, Obara T, Saito Y, Andrei G, Snoeck R, De Clercq E, Matsuda A
Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
J Med Chem. 1996 Jun 7;39(12):2392-9. doi: 10.1021/jm950853f.
The design, synthesis, and antiviral activities of 6'-homoneplanocin A (HNPA, 3) and its congeners having nucleobases other than adenine, such as 3-deazaadenine (4), guanine (5), thymine (6), and cytosine (7), were described. Starting from the known cyclopentenone derivative 8, the optically active (mesyloxy)cyclopentene derivative 15 was prepared, which was condensed with nucleobases then deprotected to give target compounds 3-7. Of these compounds, HNPA showed an antiviral activity spectrum that was comparable to, and an antiviral specificity that was higher than, that of neplanocin A. HNPA proved particularly active against human cytomegalovirus, vaccinia virus, parainfluenza virus, vesicular stomatitis virus, and arenaviruses, which is compatible with an antiviral action targeted at S-adenosylhomocysteine hydrolase. HNPA appears to be a promising candidate drug for the treatment of these viruses.
描述了6'-高衣霉素A(HNPA,3)及其具有除腺嘌呤以外的核碱基的类似物(如3-脱氮腺嘌呤(4)、鸟嘌呤(5)、胸腺嘧啶(6)和胞嘧啶(7))的设计、合成及抗病毒活性。从已知的环戊烯酮衍生物8出发,制备了光学活性的(甲磺酰氧基)环戊烯衍生物15,其与核碱基缩合然后脱保护得到目标化合物3-7。在这些化合物中,HNPA显示出与衣霉素A相当的抗病毒活性谱,且抗病毒特异性高于衣霉素A。HNPA对人巨细胞病毒、痘苗病毒、副流感病毒、水疱性口炎病毒和沙粒病毒特别有效,这与针对S-腺苷同型半胱氨酸水解酶的抗病毒作用一致。HNPA似乎是治疗这些病毒的一种有前景的候选药物。